Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for HRMY

Stock Name	Harmony Biosciences Holdings
Ticker	HRMY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4131971040

Show aggregate HRMY holdings

News associated with HRMY

Harmony Biosciences Holdings Breaks Below 200-Day Moving Average - Notable for HRMY: In trading on Tuesday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.34, changing hands as low as $33.45 per share. Harmony Biosciences Holdings Inc shares are currently trading off about 6.4% on the day. The chart - 2025-09-09 12:41:14
Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/5/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.HARMONY BIOSCIENCES HOLDINGS INC (HRMY) is a mid-cap value stock - 2025-09-05 06:14:36
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Maryland State Retirement & Pension System: Maryland State Retirement & Pension System lowered its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 13.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,165 shares of the company’s stock after selling 1,693 shares during the period. Maryland […] - 2025-08-17 05:17:01
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $51.00 Average Price Target from Brokerages: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned an average recommendation of “Buy” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-08-13 03:14:50
Harmony Biosciences (NASDAQ:HRMY) Rating Lowered to Hold at Wall Street Zen: Wall Street Zen cut shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday morning. Several other research analysts have also issued reports on HRMY. Needham & Company LLC reiterated a “buy” rating and issued a $49.00 price target on […] - 2025-08-12 04:34:55
Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/7/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.GRIFFON CORP (GFF) is a mid-cap value stock in the Appliance &am - 2025-08-07 06:54:43
Arizona State Retirement System Purchases 737 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Arizona State Retirement System grew its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 6.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,261 shares of the company’s stock after buying an additional 737 […] - 2025-07-23 05:44:46
Bank of New York Mellon Corp Has $8.70 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Bank of New York Mellon Corp lowered its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 1.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 262,238 shares of the company’s stock after selling 3,401 shares during the quarter. Bank of New York Mellon Corp’s holdings in Harmony Biosciences were worth […] - 2025-07-22 06:49:00
Truist Financial Begins Coverage on Harmony Biosciences (NASDAQ:HRMY): Research analysts at Truist Financial initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Get Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $48.00 price target on the stock. Truist Financial’s price target would indicate a potential upside of 36.17% from the company’s current price. […] - 2025-07-22 04:58:48
Louisiana State Employees Retirement System Sells 500 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Louisiana State Employees Retirement System trimmed its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.7% in the first quarter, Holdings Channel reports. The firm owned 18,000 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Harmony Biosciences were worth $597,000 as […] - 2025-07-21 05:16:49
Principal Financial Group Inc. Buys 4,753 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Principal Financial Group Inc. lifted its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 213,416 shares of the company’s stock after purchasing an additional 4,753 shares during the […] - 2025-07-16 04:38:44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.63 Consensus PT from Brokerages: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […] - 2025-06-24 02:36:53
Exchange Traded Concepts LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Exchange Traded Concepts LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 30,256 shares of the company’s stock, valued at approximately $1,004,000. Exchange Traded Concepts LLC owned 0.05% of Harmony […] - 2025-06-20 05:16:57
Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/13/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.CUREVAC BV (CVAC) is a small-cap value stock in the Biotechnolog - 2025-06-13 06:35:45
Harmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMA: In trading on Thursday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.67, changing hands as low as $34.50 per share. Harmony Biosciences Holdings Inc shares are currently trading down about 1.6% on the day. The char - 2025-06-05 12:53:08
Squarepoint Ops LLC Has $582,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Squarepoint Ops LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 125.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 16,901 shares of the company’s stock after purchasing an additional 9,411 shares during the period. Squarepoint Ops LLC’s holdings in Harmony Biosciences […] - 2025-06-04 05:06:50
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 94,011 shares of the company’s stock, valued at approximately $3,235,000. Universal Beteiligungs und Servicegesellschaft mbH owned […] - 2025-06-03 05:10:48
Nuveen Asset Management LLC Has $7.31 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Nuveen Asset Management LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 4.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 212,351 shares of the company’s stock after buying an additional 8,193 shares during the quarter. Nuveen Asset Management LLC’s holdings in Harmony Biosciences were worth […] - 2025-05-30 05:00:50
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LP: Two Sigma Advisers LP grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 21.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,900 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Two […] - 2025-05-27 06:37:02
ProShare Advisors LLC Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): ProShare Advisors LLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 47.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,190 shares of the company’s stock after purchasing an additional 4,534 shares during the period. […] - 2025-05-27 06:00:51
Bank of America Corp DE Lowers Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Bank of America Corp DE lessened its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,508 shares of the company’s stock after selling 113,458 shares during the quarter. Bank […] - 2025-05-27 05:16:49
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts: Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have been given an average rating of “Buy” by the nine brokerages that are currently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average […] - 2025-05-27 02:48:52
Comerica Bank Has $464,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Comerica Bank grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.6% in the fourth quarter, HoldingsChannel reports. The fund owned 13,495 shares of the company’s stock after acquiring an additional 2,919 shares during the period. Comerica Bank’s holdings in Harmony Biosciences were worth $464,000 as of its most […] - 2025-05-16 05:20:57
Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY): Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $49.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 46.44% from the stock’s previous close. […] - 2025-05-08 04:40:44
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Better-Than-Expected Earnings: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.96, but opened at $31.11. Harmony Biosciences shares last traded at $31.61, with a volume of 147,182 shares changing hands. The company reported […] - 2025-05-08 02:25:26
How The Pieces Add Up: IJR Headed For $129: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:51:52
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […] - 2025-05-05 02:49:06
Barclays PLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 31.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,872 shares of the company’s stock after purchasing an additional 24,010 shares during the […] - 2025-04-29 05:22:55
UBS Group Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price: Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price target lowered by UBS Group from $55.00 to $48.00 in a research note released on Monday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock. A number of other equities analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-04-29 04:28:55
Envestnet Asset Management Inc. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Envestnet Asset Management Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 53,826 shares of the company’s stock after buying an additional 1,321 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Harmony Biosciences were worth $1,852,000 at […] - 2025-04-28 04:37:03

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) HRMY holdings

Date	Number of HRMY Shares Held	Base Market Value of HRMY Shares	Local Market Value of HRMY Shares	Change in HRMY Shares Held	Change in HRMY Base Value	Current Price per HRMY Share Held	Previous Price per HRMY Share Held
2025-11-12 (Wednesday)	37,020	USD 1,241,651	USD 1,241,651	95	USD 23,864	USD 33.54	USD 32.98
2025-11-11 (Tuesday)	36,925	USD 1,217,787	USD 1,217,787	0	USD 42,833	USD 32.98	USD 31.82
2025-11-10 (Monday)	36,925	USD 1,174,954	USD 1,174,954	94	USD 17,356	USD 31.82	USD 31.43
2025-11-07 (Friday)	36,831	USD 1,157,598	USD 1,157,598	0	USD 18,047	USD 31.43	USD 30.94
2025-11-06 (Thursday)	36,831	USD 1,139,551	USD 1,139,551	94	USD -12,154	USD 30.94	USD 31.35
2025-11-05 (Wednesday)	36,737	USD 1,151,705	USD 1,151,705	0	USD 23,144	USD 31.35	USD 30.72
2025-11-04 (Tuesday)	36,737	USD 1,128,561	USD 1,128,561	95	USD 53,851	USD 30.72	USD 29.33
2025-11-03 (Monday)	36,642	USD 1,074,710	USD 1,074,710	0	USD 27,848	USD 29.33	USD 28.57
2025-10-31 (Friday)	36,642	USD 1,046,862	USD 1,046,862	0	USD -12,092	USD 28.57	USD 28.9
2025-10-30 (Thursday)	36,642	USD 1,058,954	USD 1,058,954	475	USD -1,462	USD 28.9	USD 29.32
2025-10-29 (Wednesday)	36,167	USD 1,060,416	USD 1,060,416	190	USD -5,942	USD 29.32	USD 29.64
2025-10-28 (Tuesday)	35,977	USD 1,066,358	USD 1,066,358	0	USD -16,909	USD 29.64	USD 30.11
2025-10-27 (Monday)	35,977	USD 1,083,267	USD 1,083,267	0	USD -5,037	USD 30.11	USD 30.25

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of HRMY by Blackrock for IE00BDZVHG35

Show aggregate share trades of HRMY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 95 33.630 32.600 32.703 USD 3,107 33.13
2025-11-10 BUY 94 32.065 31.140 31.232 USD 2,936 33.14
2025-11-06 BUY 94 31.580 30.340 30.464 USD 2,864 33.16
2025-11-04 BUY 95 30.890 27.660 27.983 USD 2,658 33.18
2025-10-30 BUY 475 29.500 28.740 28.816 USD 13,688 33.25
2025-10-29 BUY 190 29.320 29.755 29.711 USD 5,645 33.27
2025-10-22 SELL -380 26.270 26.490 26.468 USD -10,058 33.39 Profit of 2,630 on sale
2025-10-20 BUY 190 26.020 26.180 26.164 USD 4,971 33.47
2025-10-17 BUY 474 25.900 26.130 26.107 USD 12,375 33.52
2025-10-15 BUY 752 26.630 26.890 26.864 USD 20,202 33.56
2025-10-03 BUY 665 27.280 27.430 27.415 USD 18,231 33.63
2025-10-02 BUY 95 26.760 26.815 26.810 USD 2,547 33.67
2025-09-30 BUY 190 27.560 28.000 27.956 USD 5,312 33.75
2025-09-26 BUY 190 27.510 27.570 27.564 USD 5,237 33.83
2025-09-25 BUY 190 27.040 27.062 27.060 USD 5,141 33.87
2025-09-18 BUY 100 32.630 32.700 32.693 USD 3,269 33.87
2025-09-17 BUY 300 32.060 32.840 32.762 USD 9,829 33.89
2025-09-11 SELL -100 33.420 33.760 33.726 USD -3,373 33.90 Profit of 17 on sale
2025-09-10 BUY 200 33.210 34.410 34.290 USD 6,858 33.90
2025-07-17 SELL -198 36.430 36.710 36.682 USD -7,263 33.87 Loss of -557 on sale
2025-07-11 SELL -800 34.000 34.570 34.513 USD -27,610 33.85 Loss of -533 on sale
2025-07-02 BUY 5,500 32.110 32.370 32.344 USD 177,892 33.86
2025-06-25 BUY 200 31.570 32.225 32.159 USD 6,432 33.92
2025-06-20 BUY 816 31.890 32.600 32.529 USD 26,544 33.97
2025-06-13 BUY 818 32.970 33.260 33.231 USD 27,183 34.01
2025-06-11 BUY 188 35.140 36.390 36.265 USD 6,818 34.01
2025-06-10 BUY 188 35.850 36.470 36.408 USD 6,845 34.00
2025-06-04 SELL -94 35.160 35.960 35.880 USD -3,373 33.96 Loss of -181 on sale
2025-04-23 BUY 94 28.900 29.997 29.887 USD 2,809 34.27
2025-04-10 SELL -752 28.990 29.330 29.296 USD -22,031 34.82 Profit of 4,156 on sale
2025-04-08 SELL -94 28.130 29.762 29.599 USD -2,782 34.97 Profit of 504 on sale
2025-04-07 SELL -94 28.400 29.130 29.057 USD -2,731 35.04 Profit of 563 on sale
2025-04-04 SELL -470 29.260 30.480 30.358 USD -14,268 35.11 Profit of 2,233 on sale
2025-04-01 BUY 392 32.420 33.250 33.167 USD 13,001 35.17
2025-03-31 SELL -282 33.190 33.420 33.397 USD -9,418 35.20 Profit of 508 on sale
2025-03-21 BUY 1,392 35.280 35.510 35.487 USD 49,398 35.31
2025-03-14 SELL -1,440 32.720 33.050 33.017 USD -47,544 35.39 Profit of 3,419 on sale
2025-03-07 SELL -180 33.670 34.630 34.534 USD -6,216 35.53 Profit of 179 on sale
2025-03-04 SELL -90 32.610 33.650 33.546 USD -3,019 35.63 Profit of 188 on sale
2025-02-25 BUY 180 36.970 37.430 37.384 USD 6,729 35.78
2025-02-19 SELL -89 35.320 37.055 36.882 USD -3,282 35.86 Loss of -91 on sale
2025-02-13 BUY 267 39.075 39.900 39.818 USD 10,631 35.61
2025-02-12 BUY 89 37.840 38.790 38.695 USD 3,444 35.56
2025-02-11 BUY 356 37.740 38.665 38.573 USD 13,732 35.52
2024-12-30 SELL -3,107 34.060 34.520 34.474 USD -107,111 34.39 Loss of -266 on sale
2024-11-18 SELL -1,470 33.070 33.310 33.286 USD -48,930 34.72 Profit of 2,104 on sale
2024-11-08 SELL -98 36.080 36.080 36.080 USD -3,536 34.59 Loss of -146 on sale
2024-10-21 SELL -98 34.950 35.440 35.391 USD -3,468 0.00 Loss of -3,468 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	95	33.630	32.600	32.703	USD 3,107	33.13
2025-11-10	BUY	94	32.065	31.140	31.232	USD 2,936	33.14
2025-11-06	BUY	94	31.580	30.340	30.464	USD 2,864	33.16
2025-11-04	BUY	95	30.890	27.660	27.983	USD 2,658	33.18
2025-10-30	BUY	475	29.500	28.740	28.816	USD 13,688	33.25
2025-10-29	BUY	190	29.320	29.755	29.711	USD 5,645	33.27
2025-10-22	SELL	-380	26.270	26.490	26.468	USD -10,058	33.39 Profit of 2,630 on sale
2025-10-20	BUY	190	26.020	26.180	26.164	USD 4,971	33.47
2025-10-17	BUY	474	25.900	26.130	26.107	USD 12,375	33.52
2025-10-15	BUY	752	26.630	26.890	26.864	USD 20,202	33.56
2025-10-03	BUY	665	27.280	27.430	27.415	USD 18,231	33.63
2025-10-02	BUY	95	26.760	26.815	26.810	USD 2,547	33.67
2025-09-30	BUY	190	27.560	28.000	27.956	USD 5,312	33.75
2025-09-26	BUY	190	27.510	27.570	27.564	USD 5,237	33.83
2025-09-25	BUY	190	27.040	27.062	27.060	USD 5,141	33.87
2025-09-18	BUY	100	32.630	32.700	32.693	USD 3,269	33.87
2025-09-17	BUY	300	32.060	32.840	32.762	USD 9,829	33.89
2025-09-11	SELL	-100	33.420	33.760	33.726	USD -3,373	33.90 Profit of 17 on sale
2025-09-10	BUY	200	33.210	34.410	34.290	USD 6,858	33.90
2025-07-17	SELL	-198	36.430	36.710	36.682	USD -7,263	33.87 Loss of -557 on sale
2025-07-11	SELL	-800	34.000	34.570	34.513	USD -27,610	33.85 Loss of -533 on sale
2025-07-02	BUY	5,500	32.110	32.370	32.344	USD 177,892	33.86
2025-06-25	BUY	200	31.570	32.225	32.159	USD 6,432	33.92
2025-06-20	BUY	816	31.890	32.600	32.529	USD 26,544	33.97
2025-06-13	BUY	818	32.970	33.260	33.231	USD 27,183	34.01
2025-06-11	BUY	188	35.140	36.390	36.265	USD 6,818	34.01
2025-06-10	BUY	188	35.850	36.470	36.408	USD 6,845	34.00
2025-06-04	SELL	-94	35.160	35.960	35.880	USD -3,373	33.96 Loss of -181 on sale
2025-04-23	BUY	94	28.900	29.997	29.887	USD 2,809	34.27
2025-04-10	SELL	-752	28.990	29.330	29.296	USD -22,031	34.82 Profit of 4,156 on sale
2025-04-08	SELL	-94	28.130	29.762	29.599	USD -2,782	34.97 Profit of 504 on sale
2025-04-07	SELL	-94	28.400	29.130	29.057	USD -2,731	35.04 Profit of 563 on sale
2025-04-04	SELL	-470	29.260	30.480	30.358	USD -14,268	35.11 Profit of 2,233 on sale
2025-04-01	BUY	392	32.420	33.250	33.167	USD 13,001	35.17
2025-03-31	SELL	-282	33.190	33.420	33.397	USD -9,418	35.20 Profit of 508 on sale
2025-03-21	BUY	1,392	35.280	35.510	35.487	USD 49,398	35.31
2025-03-14	SELL	-1,440	32.720	33.050	33.017	USD -47,544	35.39 Profit of 3,419 on sale
2025-03-07	SELL	-180	33.670	34.630	34.534	USD -6,216	35.53 Profit of 179 on sale
2025-03-04	SELL	-90	32.610	33.650	33.546	USD -3,019	35.63 Profit of 188 on sale
2025-02-25	BUY	180	36.970	37.430	37.384	USD 6,729	35.78
2025-02-19	SELL	-89	35.320	37.055	36.882	USD -3,282	35.86 Loss of -91 on sale
2025-02-13	BUY	267	39.075	39.900	39.818	USD 10,631	35.61
2025-02-12	BUY	89	37.840	38.790	38.695	USD 3,444	35.56
2025-02-11	BUY	356	37.740	38.665	38.573	USD 13,732	35.52
2024-12-30	SELL	-3,107	34.060	34.520	34.474	USD -107,111	34.39 Loss of -266 on sale
2024-11-18	SELL	-1,470	33.070	33.310	33.286	USD -48,930	34.72 Profit of 2,104 on sale
2024-11-08	SELL	-98	36.080	36.080	36.080	USD -3,536	34.59 Loss of -146 on sale
2024-10-21	SELL	-98	34.950	35.440	35.391	USD -3,468	0.00 Loss of -3,468 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of HRMY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	108,472	5,348	234,711	46.2%
2025-09-18	111,025	8,894	325,984	34.1%
2025-09-17	95,108	100	187,883	50.6%
2025-09-16	128,097	12,358	317,226	40.4%
2025-09-15	135,209	0	300,082	45.1%
2025-09-12	151,923	2,495	255,315	59.5%
2025-09-11	161,565	9,535	281,361	57.4%
2025-09-10	113,595	3,149	207,043	54.9%
2025-09-09	206,183	22,917	461,817	44.6%
2025-09-08	186,749	62,734	443,997	42.1%
2025-09-05	84,992	23,242	293,945	28.9%
2025-09-04	133,575	21,855	288,006	46.4%
2025-09-03	241,435	124,278	394,903	61.1%
2025-09-02	137,281	52,607	257,771	53.3%
2025-08-29	96,248	39,096	140,248	68.6%
2025-08-28	97,910	0	133,987	73.1%
2025-08-27	104,114	500	187,482	55.5%
2025-08-26	57,186	0	93,881	60.9%
2025-08-25	84,400	0	146,263	57.7%
2025-08-22	47,530	0	213,949	22.2%
2025-08-21	84,102	2,300	140,928	59.7%
2025-08-20	98,690	0	183,563	53.8%
2025-08-19	80,039	0	168,820	47.4%
2025-08-18	83,964	303	156,507	53.6%
2025-08-15	69,487	8	121,076	57.4%
2025-08-14	71,337	844	119,721	59.6%
2025-08-13	80,927	26	168,515	48.0%
2025-08-12	76,331	23	129,342	59.0%
2025-08-11	98,526	506	189,091	52.1%
2025-08-08	75,529	0	129,887	58.1%
2025-08-07	80,052	0	140,751	56.9%
2025-08-06	98,350	6,300	192,173	51.2%
2025-08-05	267,646	547	468,852	57.1%
2025-08-04	151,988	0	230,053	66.1%
2025-08-01	111,295	34	186,988	59.5%
2025-07-31	75,187	0	140,326	53.6%
2025-07-30	92,085	0	197,551	46.6%
2025-07-29	103,043	38	188,117	54.8%
2025-07-28	122,300	0	234,869	52.1%
2025-07-25	111,075	0	232,332	47.8%
2025-07-24	76,583	0	125,414	61.1%
2025-07-23	107,722	19	215,186	50.1%
2025-07-22	258,651	1,287	348,816	74.2%
2025-07-21	210,151	0	270,413	77.7%
2025-07-18	133,326	960	251,003	53.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE